95 related articles for article (PubMed ID: 7646920)
1. Heterogeneity of intratumour proliferative activity in primary breast cancer: biological and clinical aspects.
Paradiso A; Mangia A; Barletta A; Fusilli S; Marzullo F; Schittulli F; De Lena M
Eur J Cancer; 1995 Jun; 31A(6):911-6. PubMed ID: 7646920
[TBL] [Abstract][Full Text] [Related]
2. Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers.
Collecchi P; Baldini E; Giannessi P; Naccarato AG; Passoni A; Gardin G; Roncella M; Evangelista G; Bevilacqua G; Conte PF
Eur J Cancer; 1998 Oct; 34(11):1701-4. PubMed ID: 9893655
[TBL] [Abstract][Full Text] [Related]
3. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.
Paradiso A; Tommasi S; Mangia A; Lorusso V; Simone G; De Lena M
Cancer Res; 1990 May; 50(10):2958-62. PubMed ID: 2334898
[TBL] [Abstract][Full Text] [Related]
4. Proliferative activity of primary breast cancer and of synchronous lymph node metastases evaluated by [3H]-thymidine labelling index.
Daidone MG; Silvestrini R; Valentinis B; Persici P; Mezzanotte G; Squicciarini P; Orefice S; Salvadori B
Cell Tissue Kinet; 1990 Sep; 23(5):401-8. PubMed ID: 2245439
[TBL] [Abstract][Full Text] [Related]
5. Biological and clinical relevance of proliferative activity in inflammatory breast-cancer.
Paradiso A; Mangia A; Tortora G; Schittulli F; Delena M
Int J Oncol; 1995 Mar; 6(3):563-7. PubMed ID: 21556572
[TBL] [Abstract][Full Text] [Related]
6. Cell kinetics and hormonal features in relation to pathological stage in breast cancer.
Amadori D; Bonaguri C; Nanni O; Gentilini P; Lundi N; Zoli W; Riccobon A; Vio A; Magni E; Saragoni A
Breast Cancer Res Treat; 1991 Mar; 18(1):19-25. PubMed ID: 1854976
[TBL] [Abstract][Full Text] [Related]
7. 3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer.
Silvestrini R; Daidone MG; Valagussa P; Di Fronzo G; Mezzanotte G; Mariani L; Bonadonna G
J Clin Oncol; 1990 Aug; 8(8):1321-6. PubMed ID: 2380758
[TBL] [Abstract][Full Text] [Related]
8. Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy.
Silvestrini R; Daidone MG; Mastore M; Di Fronzo G; Coradini D; Boracchi P; Squicciarini P; Salvadori B; Veronesi U
J Clin Oncol; 1993 Jun; 11(6):1150-5. PubMed ID: 8501501
[TBL] [Abstract][Full Text] [Related]
9. The validity of the labelling index in tumour studies.
Hamilton E; Dobbin J
Br J Cancer; 1985 Jan; 51(1):15-21. PubMed ID: 3966970
[TBL] [Abstract][Full Text] [Related]
10. Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease.
Paradiso A; Tommasi S; Brandi M; Marzullo F; Simone G; Lorusso V; Mangia A; De Lena M
Cancer; 1989 Nov; 64(9):1922-7. PubMed ID: 2790702
[TBL] [Abstract][Full Text] [Related]
11. Timing of breast cancer surgery within the menstrual cycle: tumor proliferative activity, receptor status and short-term clinical outcome.
Mangia A; De Lena M; Barletta A; Marzullo F; Attolico M; Stea B; Petroni S; Labriola A; Cellamare G; Digiesi G; Altieri R; Schittulli F; Paradiso A
J Exp Clin Cancer Res; 1998 Sep; 17(3):317-23. PubMed ID: 9894769
[TBL] [Abstract][Full Text] [Related]
12. The long-term prognostic significance of the thymidine labelling index in breast cancer.
Tubiana M; Pejovic MH; Chavaudra N; Contesso G; Malaise EP
Int J Cancer; 1984 Apr; 33(4):441-5. PubMed ID: 6706431
[TBL] [Abstract][Full Text] [Related]
13. Cytosol cathepsin-D content and proliferative activity of human breast cancer. The Comitato Italiano per il Controllo di Qualita del Laboratorio in Oncologia.
Paradiso A; Mangia A; Correale M; Abbate I; Ferri G; Piffanelli A; Catozzi L; Amadori D; Riccobon A; De Lena M
Breast Cancer Res Treat; 1992; 23(1-2):63-70. PubMed ID: 1446053
[TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial of adjuvant fluorouracil, epirubicin, and cyclophosphamide chemotherapy for patients with fast-proliferating, node-negative breast cancer.
Paradiso A; Schittulli F; Cellamare G; Mangia A; Marzullo F; Lorusso V; De Lena M
J Clin Oncol; 2001 Oct; 19(19):3929-37. PubMed ID: 11579113
[TBL] [Abstract][Full Text] [Related]
15. Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer.
Bertuzzi A; Daidone MG; Di Fronzo G; Silvestrini R
Breast Cancer Res Treat; 1981; 1(3):253-62. PubMed ID: 7348575
[TBL] [Abstract][Full Text] [Related]
16. Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.
Kurozumi S; Matsumoto H; Hayashi Y; Tozuka K; Inoue K; Horiguchi J; Takeyoshi I; Oyama T; Kurosumi M
BMC Cancer; 2017 May; 17(1):354. PubMed ID: 28532429
[TBL] [Abstract][Full Text] [Related]
17. Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer.
Daidone MG; Veneroni S; Benini E; Tomasic G; Coradini D; Mastore M; Brambilla C; Ferrari L; Silvestrini R
Int J Cancer; 1999 Dec; 84(6):580-6. PubMed ID: 10567902
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the thymidine labeling and Ki-67 proliferative indices in 126 breast cancer patients.
Molino A; Pedersini R; Micciolo R; Frisinghelli M; Giovannini M; Pavarana M; Nortilli R; Santo A; Manno P; Padovani M; Piubello Q; Cetto GL
Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):304-9. PubMed ID: 12607597
[TBL] [Abstract][Full Text] [Related]
19. Changes in cell kinetics induced by primary chemotherapy in breast cancer.
Daidone MG; Silvestrini R; Valentinis B; Ferrari L; Bartoli C
Int J Cancer; 1991 Feb; 47(3):380-3. PubMed ID: 1993544
[TBL] [Abstract][Full Text] [Related]
20. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
